BANK OF AMERICA CORP /DE/ - NOVABAY PHARMACEUTICALS INC ownership

NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 24 filers reported holding NOVABAY PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of NOVABAY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$0
-100.0%
3,0000.0%0.00%
Q2 2022$1,0000.0%3,0000.0%0.00%
Q1 2022$1,0000.0%3,0000.0%0.00%
Q4 2021$1,000
-50.0%
3,0000.0%0.00%
Q3 2021$2,0000.0%3,000
-0.4%
0.00%
Q2 2021$2,000
-33.3%
3,012
-3.1%
0.00%
Q1 2021$3,000
+50.0%
3,109
+3.6%
0.00%
Q4 2020$2,0000.0%3,0000.0%0.00%
Q3 2020$2,000
-33.3%
3,0000.0%0.00%
Q2 2020$3,000
+50.0%
3,0000.0%0.00%
Q1 2020$2,0000.0%3,000
-0.2%
0.00%
Q4 2019$2,000
-50.0%
3,007
-45.0%
0.00%
Q3 2019$4,000
-33.3%
5,470
+54.2%
0.00%
Q2 2019$6,000
-93.9%
3,547
-95.6%
0.00%
Q1 2019$98,000
+55.6%
81,534
-0.0%
0.00%
Q4 2018$63,000
-59.9%
81,541
-1.2%
0.00%
Q3 2018$157,000
-23.0%
82,568
+1.2%
0.00%
Q2 2018$204,000
-27.4%
81,593
+0.1%
0.00%
Q1 2018$281,000
-10.5%
81,5340.0%0.00%
Q4 2017$314,000
-13.0%
81,534
+3.8%
0.00%
Q3 2017$361,000
+19.5%
78,5340.0%0.00%
Q2 2017$302,000
+1.0%
78,534
+0.2%
0.00%
Q1 2017$299,000
+15.4%
78,3560.0%0.00%
Q4 2016$259,000
-39.6%
78,356
-25.2%
0.00%
Q3 2016$429,000104,726
+101575.7%
0.00%
Q1 2016$0103
+10200.0%
0.00%
Q4 2015$010.00%
Other shareholders
NOVABAY PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
VANGUARD GROUP INC 38,947$79,0000.00%
UBS Group AG 2,220$4,0000.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 80$00.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
DEUTSCHE BANK AG\ 5,691$11,0000.00%
CITIGROUP INC 5,504$11,0000.00%
MORGAN STANLEY 100$00.00%
MSI Financial Services Inc 24$00.00%
Renaissance Technologies 19,924$40,0000.00%
View complete list of NOVABAY PHARMACEUTICALS INC shareholders